REGISTER NOW

Current Studies

GAIN Trial: Phase 2/3 Study of COR388 in Subjects With Alzheimer's Disease

• For participants ages 55 to 80
• Have Mild to Moderate Alzheimer's Disease
• Have a Study Partner or Caregiver who can attend study visit

A Study to Evaluate Next-Dose Transition From Zolpidem to Lemborexant (LEM) for the Treatment of Insomnia

• Participants 18 years old and older
• Have insomnia and are taking Ambien (Zolpidem)

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate STS101 in the Acute Treatment of Migraine (EMERGE)

• Participants ages 18 to 65
• Experience between 2 and 8 migraines per month

Study of Azeliragon in Patients With Mild Alzheimer's Disease and Impaired Glucose Tolerance

• For participants ages 50 to 85
• Have Mild Alzheimer's Disease and elevated blood sugar or Diabetes
• Have a Study Partner or Caregiver who can attend study visit

A Study to Evaluate the Safety, Tolerability, and Efficacy of SAGE-217 Compared to Placebo in Adult Subjects With Comorbid Major Depressive Disorder and Insomnia

• Are 18 to 64 years of age
• Have had symptoms of Major Depression and Insomnia for at least 4 weeks
• Able participate in overnight sleep studies

A Study to Evaluate SAGE-217 in Adult Subjects With Major Depressive Disorder

• Are 18 - 75 years of age
• Have had symptoms of Major Depression for at least 4 weeks
• This study involves taking a study medication for 2 weeks and then follow up for 12 months.

Randomized Trial of Adult Subjects With Generalized Anxiety Disorder

• Are 18 - 65 years of age
• Have had symptoms of Generalized Anxiety Disorder for at least 1 year
• This is an 8 month long study

FreeStyle Libre Flash Glucose Monitoring System Post Approval Study for Pediatric Patients

• Are 11- 17 years of age
• Have been diagnoses with Type I or Type II diabetes
• This is a study of a blood glucose monitoring device